Streetbeat News

Products Services

TNON

Tenon Medical has announced the first publication of the MAINSAIL study, which evaluates the effectiveness of the Catamaran SI Joint Fusion System in treating adult patients with sacroiliac joint disruptions or degenerative sacroiliitis.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:37 am

IRTC

iRhythm Technologies has signed an exclusive license agreement with BioIntelliSense to enhance its ambulatory cardiac monitoring capabilities.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:37 am

SLQT

SelectQuote is expanding its operations by opening a third fulfillment facility in Olathe, Kansas, to accommodate its growing customer base. This new facility will complement its existing ones in Monaca, Pennsylvania, and Indianapolis, Indiana.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:36 am

BIIB

Biogen Inc. announced positive results from a Phase 2/3 study of a higher dose regimen of nusinersen for infants with spinal muscular atrophy, showing significant improvement in motor function.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:33 am

AZN

NVO

VANI

Vivani Medical (NASDAQ:VANI) reported positive preclinical results for its exenatide implant, showing significant liver fat reduction in obese mice. The implant, which could be a promising treatment for obesity, is set to begin clinical trials in late 2024. The news led to a 7.32% increase in VANI's stock price.

Portfolio Pulse from Vandana Singh

September 04, 2024 | 11:33 am

VANI

Vivani Medical announced that the clinical development of its exenatide implant for overweight and obese patients is on track to begin in Q4 2024 as part of its NPM-115 program.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

VANI

Vivani Medical announced that its GLP-1 (exenatide) implant achieved an 82% reduction in liver fat in an obese mouse model with a single administration, suggesting potential for twice-yearly dosing.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

VANI

Vivani Medical has announced preclinical results for its miniature, ultra long-acting GLP-1 implant, which targets liver fat reduction. This development could have implications for the company's future product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

NVDA

SPY

USO

U.S. stocks experienced a significant decline, with the S&P 500, Nasdaq, and Dow seeing their steepest losses since early August. Nvidia's sharp drop of nearly 10% contributed to the broader market decline. Weaker manufacturing data and uncertainty over Federal Reserve interest rate cuts dampened investor sentiment. Most S&P 500 sectors fell, particularly energy, tech, and communication services, while real estate and consumer staples gained. Asian and European markets also saw declines, and crude oil prices fell below $70.

Portfolio Pulse from Akanksha Bakshi

September 04, 2024 | 11:26 am

HRL

Hormel Foods Corporation (NYSE:HRL) revised its FY24 outlook due to production disruptions, causing its stock to drop. Despite beating EPS estimates, sales missed expectations, and the company faces challenges in its Retail and International segments. Hormel anticipates continued growth in its Foodservice segment and improvements in its supply chain.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 11:25 am